Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA2 | P00918 | 13/20 | 0.44 |
| ▸ | CA1 | P00915 | 12/20 | 0.44 |
| ▸ | CA9 | Q16790 | 10/20 | 0.44 |
| ▸ | CA12 | O43570 | 9/20 | 0.44 |
| ▸ | PTGS2 | P35354 | 4/20 | 0.41 |
| ▸ | PTGS1 | P23219 | 3/20 | 0.41 |
| ▸ | DRD1 | P21728 | 1/20 | 0.39 |
| ▸ | CA7 | P43166 | 1/20 | 0.36 |
| ▸ | IKBKB | O14920 | 1/20 | 0.36 |
| ▸ | CHUK | O15111 | 1/20 | 0.36 |
| ▸ | MAOA | P21397 | 1/20 | 0.34 |
| ▸ | MAOB | P27338 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5733045 | 0.84 | DRD1 (0.40) | CA2CA1CA9CA12PTGS2 | |
| SCHEMBL5732083 | 0.77 | KMT2A (0.41) | CA2CA1CA9CA12PTGS2 | |
| SCHEMBL5732775 | 0.76 | PTGS2 (0.42) | PTGS2PTGS1DRD1 | |
| SCHEMBL6002014 | 0.74 | CA12 (0.48) | CA2CA1CA9CA12PTGS2 | |
| SCHEMBL6000520 | 0.73 | CA1 (0.52) | CA2CA1CA9CA12PTGS2 | |
| SCHEMBL13129849 | 0.71 | KMT2A (0.41) | — | |
| SCHEMBL5734311 | 0.71 | CA1 (0.49) | CA2CA1CA9CA12PTGS2 | |
| SCHEMBL5822874 | 0.71 | PTGS2 (0.54) | CA2CA1CA9CA12PTGS2 | |
| SCHEMBL5823422 | 0.70 | CA2 (0.48) | CA2CA1CA9CA12PTGS2 | |
| SCHEMBL6002022 | 0.70 | CA1 (0.46) | CA2CA1CA9CA12PTGS2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0825989-A1 | SUBSTITUTED OXAZOLES FOR THE TREATMENT OF INFLAMMATION | G.D. SEARLE & CO. (US) | 1998-03-04 | — | — | EP | disclosed |